Clinical trials: Spastic Paraplegia Type 5A, Recessive
Spastic Paraplegia Type 5A, Recessive
Imaging Biomarkers in Spastic Paraplegia Type 5
This is a research study aiming to identify imaging biomarkers in patients diagnosed with spastic paraplegia type 5 (SPG5)
- Trial name
- SPIMA (NCT05174403)
- Testing
- Cerebral and spinal cord magnetic resonance imaging
- Where
- France
- Volunteers
- 10 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris